Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Net Sales
82.01
40.24
Other Operating Income
0.00
0.00
Total Operating income
82.01
40.24
Raw Material Cost
9.12
3.96
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
Employee Cost
13.64
8.35
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
32.31
11.39
Total Expenditure (Excl Depreciation)
55.07
23.70
Operating Profit (PBDIT) excl Other Income
26.94
16.54
Other Income
0.87
0.15
Operating Profit (PBDIT)
27.81
16.69
Interest
1.88
0.65
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
25.93
16.04
Depreciation
4.70
3.29
Profit Before Tax
21.23
12.77
Tax
4.42
3.27
Provisions and contingencies
0.00
0.00
Profit After Tax
16.81
9.50
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
16.81
9.50
Share in Profit of Associates
0.00
0.00
Minority Interest
-1.31
-0.09
Other related items
0.00
0.00
Consolidated Net Profit
15.50
9.41
Equity Capital
15.77
11.37
Face Value
2.0
2.0
Reserves
236.74
14.57
Earnings per share (EPS)
1.97
1.66
Diluted Earnings per share
2.49
1.85
Operating Profit Margin (Excl OI)
32.85%
41.1%
Gross Profit Margin
31.62%
39.86%
PAT Margin
20.5%
23.61%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 14.02%
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 8.67%
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 4.47%
Interest
YoY Growth in year ended Mar 2026 is 116.98%
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Gujarat Kidney With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
82.01
337.42
-255.41
-75.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
82.01
337.42
-255.41
-75.69%
Raw Material Cost
9.12
87.38
-78.26
-89.56%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
13.64
53.78
-40.14
-74.64%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
32.31
122.42
-90.11
-73.61%
Total Expenditure (Excl Depreciation)
55.07
263.58
-208.51
-79.11%
Operating Profit (PBDIT) excl Other Income
26.94
73.84
-46.90
-63.52%
Other Income
0.87
4.99
-4.12
-82.57%
Operating Profit (PBDIT)
27.81
78.83
-51.02
-64.72%
Interest
1.88
11.15
-9.27
-83.14%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
25.93
67.68
-41.75
-61.69%
Depreciation
4.70
13.59
-8.89
-65.42%
Profit Before Tax
21.23
54.08
-32.85
-60.74%
Tax
4.42
12.42
-8.00
-64.41%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
16.81
41.66
-24.85
-59.65%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
16.81
41.66
-24.85
-59.65%
Share in Profit of Associates
0.00
0.04
-0.04
-100.00%
Minority Interest
-1.31
0.00
-1.31
Other related items
0.00
0.00
0.00
Consolidated Net Profit
15.50
41.70
-26.20
-62.83%
Equity Capital
15.77
79.90
-64.13
-80.26%
Face Value
2.00
10.00
0.00
Reserves
236.74
78.28
158.46
202.43%
Earnings per share (EPS)
1.97
5.22
-3.25
-62.26%
Diluted Earnings per share
2.49
5.21
-2.72
-52.21%
Operating Profit Margin (Excl OI)
32.85%
21.88%
0.00
10.97%
Gross Profit Margin
31.62%
20.06%
0.00
11.56%
PAT Margin
20.50%
12.35%
0.00
8.15%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 40.10 Cr
in Mar 2026Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 9.90 Cr
in Mar 2026Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.14 Cr
in Mar 2026Figures in Cr
Annual - Interest
Interest 1.15 Cr
in Mar 2026Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 40.25%
in Mar 2026Figures in %






